Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jas Seehra"'
Autor:
Carolyn H. Condon, Matthew L. Sherman, Ravi Kumar, Dawn Wilson, Jas Seehra, Debbie A. Willins, Yijun Yang, Niels Borgstein, Amelia E. Pearsall, Kenneth M. Attie
Publikováno v:
Muscle & Nerve. 47:416-423
Introduction ACE-031 is a soluble form of activin receptor type IIB (ActRIIB). ACE-031 promotes muscle growth by binding to myostatin and other negative regulators of muscle mass. Methods This double-blind, placebo-controlled study evaluated the safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ac3cd34e5378556923bdae7320cb051
https://doi.org/10.1002/mus.23539
https://doi.org/10.1002/mus.23539
Autor:
Gilda Tachedjian, Martha de los Santos, Jas Seehra, Stephen P. Goff, Hans-Erik G. Aronson, John M. Mccoy
Publikováno v:
Journal of Molecular Biology. 326:381-396
The tryptophan repeat motif of the human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) is comprised of a cluster of six tryptophan residues at codons 398, 401, 402, 406, 410 and 414 that are highly conserved amongst primate lentivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2828cbc586088796a47fc6de504d688
https://doi.org/10.1016/s0022-2836(02)01433-x
https://doi.org/10.1016/s0022-2836(02)01433-x
Autor:
Jas Seehra, Les Coulton, Karin Vanderkerken, Deborah J. Heath, Holly Evans, Nicole Abdul, Peter I. Croucher, Andrew D Chantry
Publikováno v:
Cancer Treatment Reviews. 34:13-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cacbbaa77ba79653af4081bfaf9cd1b
https://doi.org/10.1016/j.ctrv.2008.03.044
https://doi.org/10.1016/j.ctrv.2008.03.044
Autor:
Kathryn W. Underwood, Aaron W. Mulivor, Samuel M. Cadena, Ravindra Kumar, Jas Seehra, R. Scott Pearsall, Rajasekhar N.V.S. Suragani
Publikováno v:
Blood. 116:978-978
Abstract 978 Myelodysplastic syndrome (MDS) is a premalignant disease characterized by ineffective hematopoiesis. MDS patients can live for extended periods of time but can develop severe anemia or may progress to acute leukemia. Current therapies re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ad42bb600190c86b657700bdbed70b5
https://doi.org/10.1182/blood.v116.21.978.978
https://doi.org/10.1182/blood.v116.21.978.978
Autor:
Ravi Kumar, Matthew L. Sherman, Denise Barbosa, Aaron W. Mulivor, R. Scott Pearsall, Jas Seehra
Publikováno v:
Blood. 114:161-161
Abstract 161 Anemia is a common and often severe side-effect of chemotherapy treatment that can alter treatment regimens and can frequently require patients to receive blood transfusions. The majority of therapies approved for anemia target the eryth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ba50b53814817ab9cea06733963cc53
https://doi.org/10.1182/blood.v114.22.161.161
https://doi.org/10.1182/blood.v114.22.161.161
Autor:
Jesse Schoonmaker, Eyal C. Attar, David T. Scadden, Jas Seehra, Alexander R. Guimaraes, Samantha Pozzi, Kenneth C. Anderson, Loredana Santo, Teru Hideshima, Chirayu G. Patel, Noopur Raje, Sonia Vallet, Diana Cirstea, Aliyah Rahemtullah, Nileshwari Vaghela, Nikhil C. Munshi, Wanling Xie, Mariateresa Fulciniti, Edie Weller, Siddhartha Mukherjee
Publikováno v:
ResearcherID
A distinct feature of multiple myeloma (MM) is the tight interaction between malignant plasma cells and their bone microenvironment, creating a niche suitable for MM growth. In particular, MM cells inhibit osteoblast (OB) differentiation and stimulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01068c0208d424bf6923b7ef8707c41
https://doi.org/10.1182/blood.v112.11.645.645
https://doi.org/10.1182/blood.v112.11.645.645